Dopamine D2-receptor antagonist with gastroprokinetic and antiemetic properties. Prepn: J. Vandenberk et al., DE 2632870; eidem, US 4066772 (1977, 1978 both to Janssen). Pharmacology: C. Ennis et al., J. Pharm. Pharmacol. 31, Suppl., 14P (1979). Gastrokinetic properties: J. M. Van Neuten et al., Life Sci. 23, 453 (1978). Receptor binding study: M. Baudry et al., Arch. Pharmacol. 308, 231 (1979). UV spectra and structural study: M. Cignitti et al., J. Mol. Struct. 350, 43 (1995). HPLC determn in serum and breast milk: A. P. Zavitsanos et al., J. Chromatogr. B 730, 9 (1999). Clinical study in diabetic gastroparesis: D. Silvers et al., Clin. Ther. 20, 438 (1998). Review of pharmacology, pharmacokinetics and therapeutic efficacy: R. N. Brogden et al., Drugs 24, 360-400 (1982); J. A. Barone, Ann. Pharmacother. 33, 429-440 (1999).
Antiemetic; gastroprokinetic.
Antiemetic; Dopamine Receptor Antagonist; Gastroprokinetic